Invention Application
- Patent Title: Akt Nucleic Acids, Polypeptides, and Uses Thereof
- Patent Title (中): Akt核酸，多肽及其用途
-
Application No.: US13195392Application Date: 2011-08-01
-
Publication No.: US20120034188A1Publication Date: 2012-02-09
- Inventor: Kun Guo , Marco F. Pagnoni , Kenneth L. Clark , Yuri D. Ivashchenko
- Applicant: Kun Guo , Marco F. Pagnoni , Kenneth L. Clark , Yuri D. Ivashchenko
- Applicant Address: US NJ Bridgewater
- Assignee: AVENTIS PHARMACEUTICALS INC.
- Current Assignee: AVENTIS PHARMACEUTICALS INC.
- Current Assignee Address: US NJ Bridgewater
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07K16/40 ; A61P9/10 ; G01N33/53 ; C12Q1/68 ; C12N5/07 ; C12N9/12 ; A61K35/76
Abstract:
The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.
Information query
